A feasibility randomised controlled trial of short-term fasting prior to CAPOX chemotherapy for stage 2/3 colorectal cancer: SWiFT protocol

Abstract Background Capecitabine and oxaliplatin (CAPOX) chemotherapy is a standard treatment for stage 2/3 colorectal cancer. Treatment is associated with dose-limiting toxicities such as neutropenia, vomiting, diarrhoea, and stomatitis. Short-term fasting prior to chemotherapy may help protect nor...

詳細記述

保存先:
書誌詳細
出版年:Pilot and Feasibility Studies
主要な著者: Ellie Shingler, Claire Perks, Georgia Herbert, Andy Ness, Charlotte Atkinson
フォーマット: 論文
出版事項: BMC 2019-11-01
主題:
Short-term fast
Dietary restriction
Colorectal cancer
Feasibility
RCT
オンライン･アクセス:http://link.springer.com/article/10.1186/s40814-019-0505-7
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

インターネット

http://link.springer.com/article/10.1186/s40814-019-0505-7

類似資料